英文名稱 | Eculizumab |
---|---|
中文名稱 | 依庫(kù)麗單抗; 依庫(kù)珠單抗 |
CAS號(hào) | 219685-50-4 |
外觀 | Colorless to light yellow liquid |
儲(chǔ)存條件 | Sealed and stored at ≤-30℃, away from light. Avoid freeze-thaw cycles. |
規(guī)格 | 庫(kù)存 | 目錄價(jià) | 會(huì)員專享價(jià) | 數(shù)量 |
---|---|---|---|---|
1 mg | In-stock | ¥3000.00 | 登錄后可見(jiàn) | |
5 mg | In-stock | ¥12500.00 | 登錄后可見(jiàn) | |
10 mg | In-stock | ¥20000.00 | 登錄后可見(jiàn) | |
50 mg | 3-5days | ¥80000.00 | 登錄后可見(jiàn) | |
100 mg | 3-5days | ¥125000.00 | 登錄后可見(jiàn) |
英文名稱 | Eculizumab |
---|---|
中文名稱 | 依庫(kù)麗單抗; 依庫(kù)珠單抗 |
CAS號(hào) | 219685-50-4 |
外觀 | Colorless to light yellow liquid |
儲(chǔ)存條件 | Sealed and stored at ≤-30℃, away from light. Avoid freeze-thaw cycles. |
Eculizumab (Anti-Complement C5) is a long-acting humanized monoclonal antibody targeting against complement C5. Eculizumab inhibits the cleavage of C5 into C5a and C5b and hence inhibits deployment of the terminal complement system including the formation of membrane attack complex (MAC). Eculizumab has the potential for haemolysis research.